Five-year evaluation of the antimicrobial susceptibility patterns of bacteria causing bloodstream infections in Iran

Journal of Infection in Developing Countries

Volumn 6, Issue 2, 2012, Pages 120-125

  Pourakbari, Babak ^a   Sadr, Alireza ^b   Ashtiani, Mohammad Taghi Haghi ^b   Mamishi, Setareh ^a,b   Dehghani, Mahdi ^b   Mahmoudi, Shima ^a   Salavati, Ali ^a   Asgari, Farhad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antimicrobial susceptibility; Bloodstream infections; Iran

Indexed keywords

AMIKACIN; AMPICILLIN; CARBENICILLIN; CEFALOTIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; OXACILLIN; PENICILLIN G; TOBRAMYCIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATE; BLOOD CULTURE; BLOODSTREAM INFECTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS; HUMAN; IRAN; KLEBSIELLA; MAJOR CLINICAL STUDY; PSEUDOMONAS AERUGINOSA; SALMONELLA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 84857187822     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.1517     Document Type: Article

References (32)

1. Reynolds R, Potz N, Colman M, Williams A, Livermore D, MacGowan A (2004) Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme. J Antimicrob Chemother 53: 1018-1032.
2. Pittet D, Li N, Woolson RF, Wenzel RP (1997) Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis 24: 1068-1078.
3. Reimer LG, Wilson ML, Weinstein MP (1997) Update on detection of bacteremia and fungemia. Clin Microbiol Rev 10: 444-465.
4. Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, Reller LB (1997) The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 24: 584-602.
5. Mylotte JM and Tayara A (2000) Blood cultures: clinical aspects and controversies. Eur J Clin Microbiol Infect Dis 19: 157-163.
6. Centers for Disease Control and Prevention (2007) Deaths and Mortality in the US 2007. Available www.cdc.gov/nchs/fastats/deaths.htm. Last accessed 29 January 2012.
7. Gransden WR (1991) Predictors for bacteraemia. J Hosp Infect 18: 308-316.
8. Haug JB, Harthug S, Kalager T, Digranes A, Solberg CO (1994) Bloodstream infections at a Norwegian university hospital, 1974-1979 and 1988-1989: changing etiology, clinical features, and outcome. Clin Infect Dis 19: 246-256.
9. Vazquez F, Mendoza MC, Villar MH, Perez F, Mendez FJ (1994) Survey of bacteraemia in a Spanish Hospital over a decade (1981-1990). J Hosp Infect 26: 111-121.
10. Karchmer AW (2000) Nosocomial bloodstream infections: organisms, risk factors, and implications. Clin Infect Dis 31: 139-143.
11. Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP (2002) Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 35: 627-630.
12. Hsueh PR, Teng LJ, Chen CY, Chen WH, Yu CJ, Ho SW, Luh KT (2002) Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan. Emerg Infect Dis 8: 827-832.
13. Sader HS, Biedenbach DJ, Jones RN (2003) Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48,440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2001). Diagn Microbiol Infect Dis 47: 361-364.
14. Mamishi S, Pourakbari B, Ashtiani MH, Hashemi FB (2005) Frequency of isolation and antimicrobial susceptibility of bacteria isolated from bloodstream infections at Children's Medical Center, Tehran, Iran, 1996-2000. Int J Antimicrob Agents 26: 373-379.
15. Pezzlo, M (1992) Aerobic bacteriology. In Isenberg, HD, editor. Clinical Microbiology Procedures Handbook. Washington, DC:. American Society for Microbiology. 1.19.1-1.20.47.
16. Reisner SB, Woods GL, Thomson RP, Larone DH, Garcia LS, Shimuzu RY (1999) Specimen collection. In Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of Clinical Microbiology, 7th ed. Washington, DC: American Society for Microbiology. 64-76.
17. NCCLS (2000) Performance standards for antimicrobial susceptibility testing, 10th informational supplement. Wayne, Pa: M100-S10(M7).
18. Wu CJ, Lee HC, Lee NY, Shih HI, Ko NY, Wang LR, KO WC (2006) Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003. J Microbiol Immunol Infect 39: 135-143.
19. Howe RA, Brown NM, Spencer RC (1996) The new threats of Gram-positive pathogens: re-emergence of things past. J Clin Pathol 49: 444-449.
20. Pfaller MA, Jones RN, Marshall SA, Coffman SL, Hollis RJ, Edmond MB (1997) Inducible amp C beta-lactamase producing Gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE). Diagn Microbiol Infect Dis 28: 211-219.
21. Schmitz FJ, Lindenlauf E, Hofmann B, Fluit AC, Verhoef J, Heinz HP (1998) The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals. J Antimicrob Chemother 42: 489-495.
22. Fedler KA, Biedenbach DJ, Jones RN (2006) Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents. Diagn Microbiol Infect Dis 56: 427-436.
23. Karlowsky JA, Jones ME, Draghi DC, Thornsberry C, Sahm DF, Volturo GA (2004) Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002. Ann Clin Microbiol Antimicrob 3: 7.
24. Neuhauser MM, Weinstein RA, Rydman R, Danziger LH, Karam G, Quinn JP (2003) Antibiotic resistance among Gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 289: 885-888.
25. Feder Jr HM (1986) Chloramphenicol: what we have learned in the last decade. South Med J 79: 1129-1134.
26. Fluit AC, Jones ME, Schmitz FJ, Acar J, Gupta R, Verhoef J (2000) Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. Clin Infect Dis 30: 454-460.
27. Sader HS, Fritsche TR, Jones RN (2005) Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003). Diagn Microbiol Infect Dis 52: 265-273.
28. El KA, Baseem H, Hall GS, Procop GW, Longworth DL (2003) Antimicrobial resistance in Cairo, Egypt 1999-2000: a survey of five hospitals. J Antimicrob Chemother 51: 625-630.
29. Oskoui M, Feizabadi MM, Amirkhani A (2003) Drug susceptibility of Streptococcus pneumoniae strains isolated in Tehran, Iran. Arch Iranian Med 6: 192-195.
30. Hanberger H, Diekema D, Fluit A, Jones R, Struelens M, Spencer R (2001) Surveillance of antibiotic resistance in European ICUs. J Hosp Infect 48: 161-176.
31. Sader HS, Jones RN, ndrade-Baiocchi S, Biedenbach DJ (2002) Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers. Diagn Microbiol Infect Dis 44: 273-280.
32. Pfaller MA, Jones RN, Doern GV, Kugler K (1998) Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 42: 1762-1770.